U.S., March 29 -- ClinicalTrials.gov registry received information related to the study (NCT06901310) titled 'A Feasibility Study in Combat Athletes with Mild Traumatic Brain Injury' on March 24.
Brief Summary: The use of Hyberbaric Oxygen Therapy (HBOT) would be a new treatment plan rather than conventional rest. If effective, this new use technology would add to the clinical treatment among mild traumatic brain injury (mTBI) patients. The use of a point of care Glial Fibrillary Acidic Protein (GFAP) biomarker would aid in clinical decision making to create a new care plan of return to sport among unarmed combat athletes who suffer from mTBI. The innovation would be a new treatment and diagnosis strategy that will protect these athletes f...